Normal antibody response after COVID-19 during treatment with cladribine

por Celius, Elisabeth G.
Publicado 2020

Breastfeeding and treatment of multiple sclerosis

por Celius, Elisabeth G
Publicado 2020

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity

por Celius, Elisabeth G., Vila, Carlos
Publicado 2018

A sensitive zonagenetic assay for rapid in vitro assessment of estrogenic potency of xenobiotics and mycotoxins.

por Celius, T, Haugen, T B, Grotmol, T, Walther, B T
Publicado 1999

Assessment of efficacy and impact on work productivity and attendance after a mandatory switch to generic second-generation antihistamines: results of a patient survey in Norway

por Thorn, Fredrik, Celius, Halvor, Ødegård, Tone, Mandla, Randeep, Hexeberg, Erik
Publicado 2011

Integration of Genome-Wide Computation DRE Search, AhR ChIP-chip and Gene Expression Analyses of TCDD-Elicited Responses in the Mouse Liver

por Dere, Edward, Lo, Raymond, Celius, Trine, Matthews, Jason, Zacharewski, Timothy R
Publicado 2011

Comments on the review article ‘Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades’

por Berg‐Hansen, P., Moen, S. M., Harbo, H. F., Celius, E. G.
Publicado 2015

Management of Severe Graves’ Hyperthyroidism in Pregnancy Following Immune Reconstitution Therapy in Multiple Sclerosis

por Hammerstad, Sara Salehi, Celius, Elisabeth G, Husby, Henrik, Sørensen, Ingvild M, Norheim, Ingrid E
Publicado 2021

CD8(+) T cell gene expression analysis identifies differentially expressed genes between multiple sclerosis patients and healthy controls

por Brorson, IS, Eriksson, AM, Leikfoss, IS, Vitelli, V, Celius, EG, Lüders, T, Berge, T, Harbo, HF, Nilsen, H, Bos, SD
Publicado 2020

Bone Turnover and Metabolism in Patients with Early Multiple Sclerosis and Prevalent Bone Mass Deficit: A Population-Based Case-Control Study

por Moen, Stine Marit, Celius, Elisabeth Gulowsen, Sandvik, Leiv, Brustad, Magritt, Nordsletten, Lars, Eriksen, Erik Fink, Holmøy, Trygve
Publicado 2012

Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness

por Penner, Iris-Katharina, Sivertsdotter, Eva Catharina, Celius, Elisabeth G., Fuchs, Siegrid, Schreiber, Karen, Berkö, Sara, Svenningsson, Anders
Publicado 2015

The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis

por Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Lauritzen, Trine, Berg-Hansen, Pål, Moen, Stine Marit, Celius, Elisabeth Gulowsen
Publicado 2020

Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS)

por Tsivgoulis, Georgios, Deftereos, Spyros, Gobbi, Claudio, Gulowsen Celius, Elisabeth, Kulakowska, Alina, Maniscalco, Giorgia, Mendes, Irene, Grigoriadis, Nicolaos
Publicado 2022

Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study

por Simonsen, Cecilia Smith, Celius, Elisabeth Gulowsen, Brunborg, Cathrine, Tallaksen, Chantal, Eriksen, Erik Fink, Holmøy, Trygve, Moen, Stine Marit
Publicado 2016

High prevalence of fatigue in contemporary patients with multiple sclerosis

por Broch, Line, Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Berg-Hansen, Pål, Skardhamar, Åshild, Ormstad, Heidi, Celius, Elisabeth Gulowsen
Publicado 2021

Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population

por Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Broch, Line, Brekke, Kamilla, Brunborg, Cathrine, Berg-Hansen, Pål, Celius, Elisabeth Gulowsen
Publicado 2022

The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression

por Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Broch, Line, Brunborg, Cathrine, Berg-Hansen, Pål, Moen, Stine Marit, Celius, Elisabeth Gulowsen
Publicado 2020

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

por Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Broch, Line, Brunborg, Cathrine, Berg-Hansen, Pål, Moen, Stine Marit, Celius, Elisabeth Gulowsen
Publicado 2021

Migraine and frequent tension-type headache are not associated with multiple sclerosis in a Norwegian case-control study

por Gustavsen, MW, Celius, EG, Winsvold, BS, Moen, SM, Nygaard, GO, Berg-Hansen, P, Lie, BA, Zwart, J-A, Harbo, HF
Publicado 2016

The instrumented single leg stance test detects early balance impairment in people with multiple sclerosis

por Berg-Hansen, Pål, Moen, Stine Marit, Klyve, Thomas Dahl, Gonzalez, Victor, Seeberg, Trine Margrethe, Celius, Elisabeth Gulowsen, Austeng, Andreas, Meyer, Frédéric
Publicado 2023